These data were further validated in The Cancer Genome Atlas (TCGA) specimens, where PML is overexpressed in KIRC, as previously observed (Wang et al, 2023), as well as in HNSC and GBM (Fig. 1D). The gene discussed is PML; the disease is glioblastoma.